Gender Difference in Statin Intervention on Blood Lipid Control among Patients with Coronary Heart Disease

by Chun-Yen Chen, Shao-Yuan Chuang, Ching-Chang Fang, Lien-Chi Huang, I-Chang Hsieh, Wen-Harn Pan, Hung-I Yeh, Chau-Chung Wu, Wei-Hsien Yin, Jaw-Wen Chen
Published 2013-06-01

P2Y12 Inhibitor Monotherapy with Clopidogrel Versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

by Po-Wei Chen, Wen-Han Feng, Ming-Yun Ho, Chun-Hung Su, Sheng-Wei Huang, Chung-Wei Cheng, Hung-I Yeh, Ching-Pei Chen, Wei-Chun Huang, Ching-Chang Fang, Hui-Wen Lin Sheng-Hsiang Lin, I-Chang Hsieh, Yi-Heng Li
Published 2020-06-01

Effect of aspirin treatment duration on clinical outcomes in acute coronary syndrome patients with early aspirin discontinuation and received P2Y12 inhibitor monotherapy.

by Ming-Yun Ho, Po-Wei Chen, Wen-Han Feng, Chun-Hung Su, Sheng-Wei Huang, Chung-Wei Cheng, Hung-I Yeh, Ching-Pei Chen, Wei-Chun Huang, Ching-Chang Fang, Hui-Wen Lin, Sheng-Hsiang Lin, I-Chang Hsieh, Yi-Heng Li
Published 2021-01-01

Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan

by Jiann-Shing Jeng, Wei-Hsian Yin, Chin-Chou Huang, Shao-Yuan Chuang, Hung-I Yeh, Ching-Chang Fang, Tsung-Hsien Lin, Kuo-Yang Wang, Wei-Kung Tseng, Lien-Chi Huang, Kwo-Chang Ueng, I-Chang Hsieh, Yi-Heng Li, Wen-Harn Pan, Chau-Chung Wu, Jaw-Wen Chen
Published 2015-10-01

Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan.

by Li-Ting Ho, Wei-Hsian Yin, Shao-Yuan Chuang, Wei-Kung Tseng, Yen-Wen Wu, I-Chang Hsieh, Tsung-Hsien Lin, Yi-Heng Li, Lien-Chi Huang, Kuo-Yang Wang, Kwo-Chang Ueng, Ching-Chang Fang, Wen-Harn Pan, Hung-I Yeh, Chau-Chung Wu, Jaw-Wen Chen, Taiwanese Secondary Prevention for patients with AtheRosCLErotic disease (T-SPARCLE) Registry Investigators
Published 2015-01-01